High SEH1L expression was a risk factor for shorter progression free interval (PFI) in ACC, KICH, LIHC, PAAD, uterine corpus endometrial carcinoma (UCEC) and uveal melanoma (UVM) (Fig. 2B). Here, SEH1L is linked to uveal melanoma.